NASDAQ:ALDX

Aldeyra Therapeutics Stock Forecast

etoro logo Buy ALDX
*Your capital is at risk
$1.69
-0.0300 (-1.74%)
At Close: Jul 17, 2026
AI Analysis AI Analysis of ALDX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ALDX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Aldeyra Therapeutics stock upgraded to Sell Candidate
(Updated on Jul 17, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 16, 2026 Loss -1.74%

The Aldeyra Therapeutics stock price fell by -1.74% on the last day (Friday, 17th Jul 2026) from $1.72 to $1.69. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 5.15% from a day low at $1.65 to a day high of $1.74. The price has fallen in 7 of the last 10 days and is down by -25.55% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 1 million shares were bought and sold for approximately $1.98 million.

Given the current short-term trend, the stock is expected to rise 25.26% during the next 3 months and, with a 90% probability hold a price between $2.12 and $3.16 at the end of this 3-month period.

ALDX Signals & Forecast

There are few to no technical positive signals at the moment. The Aldeyra Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $1.94 and $1.91. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 01, 2026, and so far it has fallen -30.45%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Aldeyra Therapeutics stock

Aldeyra Therapeutics finds support from accumulated volume at $1.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0850 between high and low, or 5.15%. For the last week, the stock has had daily average volatility of 7.31%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALDX) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Aldeyra Therapeutics to open at $1.69, and during the day (based on 14 day Average True Range), to move between $1.60 and $1.78, which gives a possible trading interval of +/-$0.174 (+/-10.82%) up or down from last closing price. If Aldeyra Therapeutics takes out the full calculated possible swing range there will be an estimated 10.82% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.68 (0.59%) than the resistance at $1.72 (1.78%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aldeyra Therapeutics stock A Buy?

The Aldeyra Therapeutics stock holds several negative signals and despite the positive trend, we believe Aldeyra Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.938 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $1.69 ( 0.0986%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ALDX Performance

Trading levels for ALDX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.78 5.13%
R2 1.74 3.21%
R1 1.72 2.02%
Price 1.69
S1 1.66 -1.82%
S2 1.64 -3.01%
S3 1.61 -4.93%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.83 8.28%
R2 1.78 5.33%
R1 1.72 1.78%
Price 1.69
S1 1.68 -0.592%
S2 1.60 -5.33%
S3 1.55 -8.28%

FAQ

What is the symbol for Aldeyra Therapeutics Stock and on which exchange is it traded?
The symbol for Aldeyra Therapeutics is ALDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aldeyra Therapeutics Stock?
The Aldeyra Therapeutics stock holds several negative signals and despite the positive trend, we believe Aldeyra Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Aldeyra Therapeutics Stock?
Aldeyra Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aldeyra Therapeutics Stock.

What's the current price of Aldeyra Therapeutics Stock?
As of the end of day on the Jul 17, 2026, the price of an Aldeyra Therapeutics (ALDX) share was $1.69.

What is the 52-week high and low for Aldeyra Therapeutics Stock?
The 52-week high for Aldeyra Therapeutics Stock is $6.18 and the 52-week low is $1.07.

What is the market capitalization of Aldeyra Therapeutics Stock?
As of the Jul 17, 2026, the market capitalization of Aldeyra Therapeutics is 101.943M.

When is the next earnings date for Aldeyra Therapeutics?
The upcoming earnings date for Aldeyra Therapeutics is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT ALDEYRA THERAPEUTICS
Aldeyra Therapeutics
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
0.578% Jul 13
SRPT
$17.02
1.18% Jun 29
JLL
$299.78
10.30% Jun 24
NMRK
$15.02
3.86% Jun 24
CAG
$13.43
6.29% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE